ARCHIVES

Control-Arm CML Patients In Phase III Gleevec Study Allowed To Switch.

This article is from The Cancer Letter archive.

Vol. 28 No. 04 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

Baltimore Reports On New Method To Aid Leukemia Therapy Design

May 20, 1977

Non-Adherence To Protocol Explains Outcome Differences In Hispanic Children With ALL

December 31, 2010

Gori To Leave NCI For Job At Franklin Institute

April 18, 1980

DeVita Reshuffling NCI Office Space

April 18, 1980

Breast Asymmetry Predicts Breast Cancer, Study Finds

March 31, 2006

12 Minority CCOPs Awardees Names, San Antonio Gets 2

September 21, 1990